Edition:
United Kingdom

Santhera Pharmaceuticals Holding AG (SANN.S)

SANN.S on Swiss Exchange

27.80CHF
13 Dec 2017
Change (% chg)

CHF0.15 (+0.54%)
Prev Close
CHF27.65
Open
CHF28.10
Day's High
CHF28.90
Day's Low
CHF27.60
Volume
59,032
Avg. Vol
64,231
52-wk High
CHF82.00
52-wk Low
CHF25.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 10.86 -3.620
FY 2016 Dec '16 11.82 -2.775
Jun '16 7.21 -2.870
FY 2015 Dec '15 2.87 2.142
Jun '15 1.46 -1.280
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 2 23.00 24.00 22.00 52.20
Year Ending Dec-18 2 45.40 46.00 44.80 102.43
Earnings (per share)
Year Ending Dec-17 2 -5.82 -5.72 -5.91 2.89
Year Ending Dec-18 2 -2.11 -1.16 -3.06 6.03
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. 80.56 40.91 45.62
P/E Low - Last 5 Yrs. 80.56 23.80 24.34
Beta 0.77 0.90 0.88
Price to Sales (TTM) 10.47 3.93 5.40
Price to Book (MRQ) 4.30 4.81 5.38
Price to Tangible Book (MRQ) 7.88 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg 0.00 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 50.61 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 125.11 4.66 5.38
Sales - 5 Yr. Growth Rate 42.27 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.13 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago -778.32 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 33.33 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 7.73 2.11 2.18
Current Ratio (MRQ) 8.57 2.88 2.98
LT Debt to Equity (MRQ) 94.97 9.47 11.56
Total Debt to Equity (MRQ) 94.97 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 82.69 55.14 54.83
Gross Margin - 5 Yr. Avg. 80.71 52.29 52.40
EBITD Margin (TTM) -149.78 -- --
EBITD - 5 Yr. Avg -254.40 18.46 15.24
Operating Margin (TTM) -164.39 14.50 7.76
Operating Margin - 5 Yr. Avg. -247.87 14.42 10.75
Pre-Tax Margin (TTM) -170.74 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -244.33 14.74 11.17
Net Profit Margin (TTM) -177.04 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -242.25 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 302,427 953,213,828 864,673,362
Net Income/Employee (TTM) -535,413 112,151,383 101,717,513
Receivable Turnover (TTM) 5.17 5.60 5.76
Inventory Turnover (TTM) 0.51 2.58 3.34
Asset Turnover (TTM) 0.19 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.17 11.42 11.00
Return on Assets - 5 Yr. Avg. -31.14 13.00 12.43
Return on Investment (TTM) -37.59 14.86 14.46
Return on Investment - 5 Yr. Avg. -34.37 17.00 16.28
Return on Equity (TTM) -55.62 16.28 16.05
Return on Equity - 5 Yr. Avg. -37.23 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 340.48 143.46 42.27
EPS (TTM) % -607.02 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Santhera Pharmaceuticals Holding AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -45.69 -47.69 5 25
13 Week -43.20 -45.47 13 37
26 Week -49.60 -52.93 22 30
52 Week -29.48 -37.72 67 12
YTD -28.68 -36.64 60 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.83%
# of Holders: 44
Total Shares Held: 1,937,526
3 Mo. Net Change: 602,302
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 9
# Reduced Positions: 8
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.